Event

15th World CB & CDx Summit

“Returning for its 15th anniversary this September, the World Clinical Biomarkers & Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx developers, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring.” – World CB & CDx

Secure your 1:1 appointment below and learn more about:

Location

Boston, MA, USA

Date

September 22 - 25, 2025

Request a meeting with the ANGLE team at the 15th World CB & CDx Summit

 A man with short brown hair, wearing a shirt and suit jacket

Brett Swansiger

Chief Commercial Officer

Brett plays a key role in our global corporate partnerships and overseeing our commercial teams in their biopharma services activities and research/clinical product solutions. Brett has over 20 years of commercial leadership, international business development, and business to business sales.

Connect with Brett on LinkedIn:
 Mark Rogers

Mark Rogers

Senior US Biopharma Partnering Lead

Working within ANGLE’s Biopharma Services team, Mark is focused on the United States and Canada. With over 20 years of experience in life sciences and clinical diagnostics, his expertise includes strategic pharmaceutical partnerships, diagnostic development, and clinical genomics.

Connect with Mark on LinkedIn:
 A man with short brown hair, wearing a shirt and suit jacket

Brett Swansiger

Chief Commercial Officer

Brett plays a key role in our global corporate partnerships and overseeing our commercial teams in their biopharma services activities and research/clinical product solutions. Brett has over 20 years of commercial leadership, international business development, and business to business sales.

Connect with Brett on LinkedIn:
 Mark Rogers

Mark Rogers

Senior US Biopharma Partnering Lead

Working within ANGLE’s Biopharma Services team, Mark is focused on the United States and Canada. With over 20 years of experience in life sciences and clinical diagnostics, his expertise includes strategic pharmaceutical partnerships, diagnostic development, and clinical genomics.

Connect with Mark on LinkedIn:

Request a meeting with